
|Videos|July 27, 2022
Institutional Perspectives in Neurology, Chaired by Annette Okai, MD
Author(s)NeurologyLive® Staff
Chaired by Annette Okai, MD, of North Texas Institute of Neurology & Headache, the presentations also feature Fernando Cuascut, MD, MPH, of Baylor College of Medicine; and Lauren Tardo, MD, and Rebecca Romero, MD, of UT Southwestern Medical Center. [WATCH TIME: 1 hour, 18 minutes]
Advertisement
NeurologyLive® State of the Science events are short meetings designed to educate neurologists and APPs on the clinical benefits associated with the new science driving new thinking. Our renowned faculty focuses on the most relevant topics to ultimately improve patient care.
TOPICS INCLUDE:
- The Evolving Landscape of Multiple Sclerosis - Mechanisms of Action and Targets of Treatment — Fernando Cuascut, MD, MPH
- FDA Approved Oral Medications for MS — Lauren Tardo, MD
- FDA Approved B Cell Depleting Medications for MS — Rebecca Romero, MD
- Emerging Treatments for MS — Annette Okai, MD
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Roche Unveils PrevenTRON, a Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High Risk of Alzheimer Decline
2
Alzheimer's Association Launches PROTECT-Cog Combination Prevention Trial
3
Sanofi's Oral TREM2 Agonist SAR448851 Advances to Phase 2 TREMHANCE Trial in Early Alzheimer Disease
4
Building the Foundation for Earlier Alzheimer Disease Diagnosis
5

















